1 September 2024

Starpharma to present at OTCQX Virtual Investor Conference

Melbourne, Australia; Starpharma (ASX: SPL, OTCQX: SPHRY) today announced that as part of its OTCQX investor communications, a pre-recorded presentation by Chief Executive Officer Dr Jackie Fairley will be broadcast at VirtualInvestorConferences.com on Thursday 12 April 2018 at 10:30am (US ET time). The presentation is part of OTCQX’s virtual investor conference dedicated to international companies.

 

The presentation will provide an overview of Starpharma for new investors; and highlight developments of the company’s VivaGel® and DEP® portfolios.  

 

Interested parties are able to register at www.VirtualInvestorConferences.com or at the following link: https://edge.media-server.com/m6/p/qdcoump5. An on-demand archive of the presentation will be available for 90 days at www.VirtualInvestorConferences.com.

 

The slide presentation is also available here ( pdf file, 1MB).

This contains certain forward-looking statements.

Important Notice

This website is intended for people seeking information about Starpharma for investment and business purposes. This website contains information about products that may not be available, or approved, in all countries, or may be available under different trademarks, or for different indications. Individuals seeking information about a Starpharma product should visit the relevant product website in their country of residence or consult a healthcare provider. Nothing contained on this site should be considered a solicitation, promotion, or advertisement for any product, including those under development. Any information on this site is not intended to provide medical advice nor should be used as a substitute for the advice provided by a doctor or other healthcare provider.